Triple-negative breast cancer (TNBC) is characterized by the lack of detectible expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/Neu/ErbB2) [1]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.